Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

(2010) Wendy De Roock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

International network of cancer genome projects

(2010) Thomas J. Hudson (Chairperson) et al.   NATURE

Advanced pancreatic carcinoma: current treatment and future challenges

(2010) Anastasios Stathis et al.   Nature Reviews Clinical Oncology

A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival

(2009) Anurag Singh et al.   CANCER CELL

Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras

(2009) Sharon Y. Gidekel Friedlander et al.   CANCER CELL

FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt

(2009) Huadong Pei et al.   CANCER CELL

SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

(2009) A. Blackford et al.   CLINICAL CANCER RESEARCH

Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer

(2009) Andrew V. Biankin et al.   GASTROENTEROLOGY

Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer

(2008) Y. Balagurunathan et al.   MOLECULAR CANCER THERAPEUTICS

Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening

(2008) D.-H. Fu et al.   MOLECULAR CANCER THERAPEUTICS

Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer

(2008) Kevin A. Kwei et al.   PLoS Genetics